CAS 177036-94-1 Tsafta > 99.0% (HPLC) API Babban Tsabta

Takaitaccen Bayani:

Saukewa: 177036-94-1

Tsafta:> 99.0% (HPLC)

Bayyanar: Fari ko Kashe-Farin Foda

Maganin Hawan Jijiyoyin Jijiyoyi (PAH)

API High Quality, Kasuwancin Kasuwanci

E-Mail: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Abubuwan Sinadarai:

Sunan Sinadari (S)-2-[(4,6-Dimethylpyrimidin-2-yl) oxy] -3-Methoxy-3,3-Diphenylpropionic Acid
Makamantu (+-) (2S) -2-((4,6-Dimethylpyrimidin-2-yl) oxy) -3-Methoxy-3,3-Diphenylpropanoic Acid
Lambar CAS 177036-94-1
Matsayin Hannun jari A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton
Tsarin kwayoyin halitta Saukewa: C22H22N2O4
Nauyin Kwayoyin Halitta 378.43
Takamaiman Juyawa [α]D20 +170.0° zuwa +176.0° (C=0.5, MeOH)
Matsayin narkewa 172.0 ~ 178.0 ℃
Solubility Soluble sosai a cikin methanol;Mai narkewa a cikin Ethanol, acetone;Mara narkewa a cikin Ruwa
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Fari ko Kashe-Farin Foda
Ganewa HPLC;NMR;LC-MS
Abubuwa masu alaƙa  
Rashin Tsabtace Mutum ≤0.50%
Jimlar ƙazanta <1.00%
Asara akan bushewa ≤0.50%
Ragowa akan Ignition ≤0.20%
Karfe masu nauyi ≤20ppm
Tsarkake / Hanyar Bincike > 99.0% (HPLC)
Matsayin Gwaji Matsayin Kasuwanci
Amfani Matsakaicin Magunguna

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi

Amfani:

1

FAQ:

Aikace-aikace:

(CAS: 177036-94-1) APIne mai zaɓaɓɓen endothelin-A (ETA) antagonist mai karɓa wanda aka gabatar don maganin baka na marasa lafiya tare da hauhawar jini na huhu (PAH), don inganta ƙarfin motsa jiki da jinkirta jinkirin asibiti.PAH wata cuta ce da ba a sani ba na ƙananan jijiyoyi na huhu wanda ke da alaƙa da haɓakar ƙwayoyin cuta da gyare-gyare, wanda ya haifar da ci gaba a cikin juriya na huhu da kuma matsa lamba na huhu, kuma a ƙarshe, rashin cin nasara na ventricular dama da kuma mutuwa da wuri.Alamomin farko na PAH sun haɗa da farawa a hankali na ƙarancin numfashi, gajiya, bugun zuciya, edema, da suma.Endothelin-1 (ET-1), wani m vasoconstrictor da santsi tsoka mitogen, shi ne mabuɗin mai ba da gudummawa ga haɓakar cutar, kuma ana yin sulhunta tasirinta ta hanyar kunna ETA da masu karɓar ETB.A watan Yuni na 2007, FDA ta ba da izinin (CAS: 177036-94-1) API don maganin PAH sau ɗaya kowace rana.

Ku rubuta sakonku anan ku aiko mana